Observational studyInternational journal of urology : official journal of the Japanese Urological Association2026
Impact of Hormonal and Radiation Therapy on Bladder Outlet Obstruction in High-Risk Localized Prostate Cancer: A Prospective Pressure-Flow Study.
Observational study in International journal of urology : official journal of the Japanese Urological Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incarcerated inguinoscrotal bladder herniation: A case report highlighting large bladder herniation with intrasaccular calculi.Urology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThere are few reports investigating urodynamic changes after radiotherapy and hormonal therapy (HT) for prostate cancer. We prospectively evaluated differences in bladder outlet obstruction (BOO) using pressure-flow studies (PFS) before and after HT and radiotherapy in patients with high-risk localized or locally advanced prostate cancer.
methodsThis single-center prospective observational study enrolled 20 consecutive men scheduled for HT followed by intensity-modulated radiotherapy. PFS, uroflowmetry, symptom questionnaire surveys, and magnetic resonance imaging (MRI) were performed at baseline, 6 months, and 24 months after initiation of HT. Radiotherapy was initiated after the 6-month evaluation. The primary endpoint was the change in the bladder outlet obstruction index (BOOI), defined as the difference between baseline and 24 months after initiation of HT.
resultsAll patients completed the 24-month protocol. Mean BOOI decreased from 44.3 ± 23.4 at baseline to 26.8 ± 25.0 at 6 months (p < 0.01) and remained significantly reduced at 33.2 ± 29.1 at 24 months (p < 0.05). Prostate volume was reduced significantly by 43% at 6 months (p < 0.01) and by 41% at 24 months (p < 0.01). MRI demonstrated resolution of malignant lesions by 6 months in all patients, with no recurrence at 24 months. Three patients (15%) exhibited a BOOI reduction > 30, and all three had periurethral tumors prior to treatment.
conclusionThis first prospective PFS-based study demonstrates that combined HT and radiotherapy improve BOO, particularly during HT, likely through reduction of prostate and tumor volume. Patients with periurethral tumors may achieve greater improvement in BOO. These findings underscore the importance of considering treatment-induced BOO changes in therapeutic decision-making.
trial registrationClinicalTrials.gov identifier: UMIN-CTR; UMIN000040312.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.